FISH – PRENATAL COMPREHENSIVE SCREENING PANEL 1 Test
Cost: AED 2570.0
Symptoms Diagnosis: Aneuploidy detection for Trisomy 13, 18, 21 & Sex chromosomes, Microdeletions for DiGeorge syndrome, Prader Willi syndrome & William Beuren syndrome
Price: 2570.0 AED
Sample Condition: 10 mL (7 mL min.) Amniotic fluid in a sterile screw capped container. Ship at 18-22°C. DO NOT FREEZE. Sample to be taken after 15 weeks gestation. Duly filled Prenatal Genetic Testing Consent Form (Form 18) & Chromosome & FISH analysis Requisition Form (Form 17) is mandatory.
Report Delivery: Sample Daily by 4 pm; Report 4 days
Method: FISH
Test Type: Prenatal Diagnosis
Doctor: Gynecologist
Test Department: CYTOGENETICS
Pre Test Information: Sample should be taken after 15 weeks gestation. Duly filled Prenatal Genetic Testing Consent Form (Form 18) & Chromosome & FISH analysis Requisition Form (Form 17) is mandatory.
Test Details
The FISH (Fluorescence In Situ Hybridization) – Prenatal Comprehensive Screening Panel 1 test is a genetic test performed during pregnancy to screen for certain chromosomal abnormalities in the fetus. It uses fluorescent probes to detect specific chromosomal regions or genes, allowing for the identification of abnormalities such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome).
The test is typically recommended for pregnant women who have an increased risk of having a baby with a chromosomal abnormality, based on factors such as maternal age, family history, or abnormal results from other prenatal screening tests. It is usually performed on cells obtained from the amniotic fluid (amniocentesis) or the placenta (chorionic villus sampling).
The FISH – Prenatal Comprehensive Screening Panel 1 test provides a rapid and accurate assessment of these common chromosomal abnormalities, allowing for early detection and informed decision-making for the expectant parents.
It is important to note that while the test is highly accurate, it does not screen for all possible chromosomal abnormalities, and further testing may be recommended if other abnormalities are suspected. It is essential to consult with a healthcare provider or genetic counselor to discuss the benefits, limitations, and potential risks associated with the FISH – Prenatal Comprehensive Screening Panel 1 test before making a decision to undergo the test.
| Test Name | FISH – PRENATAL COMPREHENSIVE SCREENING PANEL 1 Test |
|---|---|
| Components | *Aneuploidy detection for Trisomy 13, 18, 21 & Sex chromosomes * Microdeletions for DiGeorge syndrome, Prader Willi syndrome & William Beuren syndrome |
| Price | 2570.0 AED |
| Sample Condition | 10 mL (7 mL min.) Amniotic fluid in a sterile screw capped container. Ship at \n18-22?\u00f8C. DO NOT FREEZE. Sample to be taken after 15 weeks gestation. Duly filled Prenatal Genetic Testing Consent Form (Form 18) & Chromosome & FISH analysis Requisition Form (Form 17) is mandatory. |
| Report Delivery | Sample Daily by 4 pm; Report 4 days |
| Method | FISH |
| Test type | Prenatal Diagnosis |
| Doctor | Gynecologist |
| Test Department: | CYTOGENETICS |
| Pre Test Information | Sample should be taken after 15 weeks gestation. Duly filled Prenatal Genetic Testing Consent Form (Form 18) & Chromosome & FISH analysis Requisition Form (Form 17) is mandatory. |
| Test Details |
The FISH (Fluorescence In Situ Hybridization) – Prenatal Comprehensive Screening Panel 1 test is a genetic test performed during pregnancy to screen for certain chromosomal abnormalities in the fetus. It uses fluorescent probes to detect specific chromosomal regions or genes, allowing for the identification of abnormalities such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome). The test is typically recommended for pregnant women who have an increased risk of having a baby with a chromosomal abnormality, based on factors such as maternal age, family history, or abnormal results from other prenatal screening tests. It is usually performed on cells obtained from the amniotic fluid (amniocentesis) or the placenta (chorionic villus sampling). The FISH – Prenatal Comprehensive Screening Panel 1 test provides a rapid and accurate assessment of these common chromosomal abnormalities, allowing for early detection and informed decision-making for the expectant parents. It is important to note that while the test is highly accurate, it does not screen for all possible chromosomal abnormalities, and further testing may be recommended if other abnormalities are suspected. It is essential to consult with a healthcare provider or genetic counselor to discuss the benefits, limitations, and potential risks associated with the FISH – Prenatal Comprehensive Screening Panel 1 test before making a decision to undergo the test. |
